Daiichinkyo Co (FRA:D4S) Treasury Stock: €-779 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:D4S Daiichi Sankyo Co Ltd FRA:D4S
79 GF Score
Price €13.68
GF Value €28.75
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Daiichinkyo Co Treasury Stock?

Daiichinkyo Co FRA:D4S -9.94% 79 Treasury Stock is €-779 Mil as of Jun. 2026. GuruFocus rates FRA:D4S with a GF Score™ of 79/100 and a GF Value™ of €28.75 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Treasury stock is the portion of shares that a company keeps in their own treasury. Daiichinkyo Co's treasury stock for the quarter that ended in Jun. 2026 was €-779 Mil.

Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place.

Daiichinkyo Co Treasury Stock Historical Data

* Premium members only.

The historical data trend for Daiichinkyo Co's Treasury Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Daiichinkyo Co Treasury Stock Chart

Daiichinkyo Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Treasury Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only -287.02 -257.20 -224.93 -914.22 -1,351.84

Daiichinkyo Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Treasury Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -940.51 -900.95 -856.26 -1,351.84 -779.27
FRA:D4S
79GF Score
Daiichi Sankyo Co Ltd FRA:D4S
Treasury Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Daiichinkyo Co Treasury Stock Calculation

The portion of shares that a company keeps in their own treasury. Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place. These shares don't pay dividends, have no voting rights, and should not be included in shares outstanding calculations.

Frequently Asked Questions Learn more about Treasury Stock →
What does a Treasury Stock of €-779 Mil mean?
Daiichinkyo Co (FRA:D4S) has a Treasury Stock of €-779 Mil as of Jun. 2026. Treasury stock is a contra-equity item that records the amount of stock not issued to shareholders. View historical data for Daiichinkyo Co and its competitors.
Is Daiichinkyo Co's Treasury Stock too high?
Daiichinkyo Co's current Treasury Stock is €-779 Mil. Overall, Daiichinkyo Co has a GF Score™ of 79/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Daiichinkyo Co's Treasury Stock compare to LLY and JNJ?
Daiichinkyo Co's Treasury Stock of €-779 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Treasury Stock for a Drug Manufacturers company?
A good Treasury Stock depends on the Drug Manufacturers industry context. However, Treasury Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Treasury Stock mean?
A high Treasury Stock can signal that a stock is expensive relative to its fundamentals. Treasury stock is a contra-equity item that records the amount of stock not issued to shareholders. View historical data for Daiichinkyo Co and its competitors. Daiichinkyo Co's current Treasury Stock is €-779 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Daiichinkyo Co stock overvalued right now?
Based on GuruFocus' analysis, Daiichinkyo Co (FRA:D4S) is currently considered Significantly Undervalued. The stock's GF Value™ is €28.75, compared to a current price of €13.68 — trading 52.4% below its estimated fair value. The current Treasury Stock is €-779 Mil. Daiichinkyo Co's overall GF Score™ is 79/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Treasury Stock calculated?
Treasury Stock is calculated from a company's financial statements. For Daiichinkyo Co (FRA:D4S), the current Treasury Stock is €-779 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Daiichinkyo Co (FRA:D4S) Overvalued in 2026?

Based on GuruFocus' analysis, Daiichinkyo Co stock appears to be undervalued. The current stock price of €13.68 is trading 52.4% below its estimated GF Value™ of €28.75. GuruFocus considers Daiichinkyo Co to be Significantly Undervalued.

Key valuation signals for FRA:D4S:

  • Treasury Stock: €-779 Mil
  • GF Value™: €28.75 vs. price of €13.68 (52.4% below fair value)
  • GF Score™: 79/100 with 3 warning signs

No single metric tells the full story. See the FRA:D4S stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Daiichinkyo Co Business Description

Address 3-5-1, Nihonbashi-Honcho, Chuo-ku, Tokyo, JPN, 103-8426
Daiichi Sankyo was established by the merger of Daiichi Pharmaceuticals and Sankyo in 2005. As of 2024, approximately one quarter of revenue comes from its Japan businesses, which will shrink in the future as the company expands its global footprint. Its primary growth driver is its leading platform of antibody drug conjugates, or ADCs. Its lead ADCs are Enhertu (HER2), Datroway (TROP2), I-DXd (B7-H3), HER3-DXd (HER3), and R-DXd (CDH6). Enhertu was first approved in the US in December 2019, and Datroway was first approved in January 2025.
79GF Score

Get the complete analysis for FRA:D4S

Treasury Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€13.68
Price
€28.75
GF Value